CBIIF News and Press, Skylight Health Group From 11/15/19

Point Roberts, WA and Delta, BC - November 15, 2019 (Investorideas.com Newswire) Investorideas.com , a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories in mining, cannabis, food & beverage, greentech, and cyberse...

TORONTO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence-driven from the point-of-care to the medical cannabis community, today announced Prad ...

CB2 Insights ( OTCQB:CBIIF ): Q3 GAAP EPS of -C$0.013. More news on: CB2 Insights Inc., Earnings news and commentary, , Read more ...

TORONTO, Nov. 08, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, announced its results...

CB2 Insights’ Q3 2019 preliminary unaudited revenue saw a sequential growth of approximately 29% compared to the previous quarter Company’s Q3 preliminary Adjusted-EBITDA loss was significantly reduced by 64% compared to the previous quarter After three acquisitions in...

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) , an Ontario-based cannabis company recognized for its premium products and services, has entered into a technology and multi-phase research agreement with CB2 Insights Inc. (CSE: CBII) (OTCQB: CBIIF) ("CB2"), a leading data-driven company focused on...

Partnership to focus on implementing a medical product development strategy for VIVO’s global medical cannabis offering, utilizing CB2 Insights’ leading technology platform Sail and research capabilities   Joint venture will aim to increase the collection of real word d...

CB2 Insights (CSE: CBII ,OTCQB:CBIIF) CEO Prad Sekar believes that the medical cannabis industry is moving towards the use of contract research organizations (CROs) for validating product health claims. CROs are third-party organizations that help drug manufacturers take a product from f...

Medical cannabis is quickly gaining legitimacy, but healthcare providers and patients alike are having trouble accessing vital information on the subject. Since California took the plunge by becoming the world’s first medical cannabis jurisdiction in 1996, the efficacy of using cannab...

Medicinal cannabis data group CB2 Insights Inc (CSE:CBII) (OTCQB:CBIIF) has announced it is expanding its market presence in the UK, boosting CBII stock by 5%. The company, which specializes in research and data collection to offer a suite of technology solutions in the medicinal c...